{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:42:08Z","timestamp":1695505328104},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T00:00:00Z","timestamp":1278806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00520-010-0940-8","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T22:24:20Z","timestamp":1278887060000},"page":"1211-1216","source":"Crossref","is-referenced-by-count":10,"title":["Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT"],"prefix":"10.1007","volume":"19","author":[{"given":"Maria J. G. T.","family":"R\u00fcping","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Keulertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg J.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"L\u00f6venich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"S\u00f6hngen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,11]]},"reference":[{"key":"940_CR1","unstructured":"National Cancer Institute (2010) Oral Complications of Chemotherapy and Head\/Neck Radiation. National Cancer Institute, Bethesda, MD, USA"},{"key":"940_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/1024533021000037216","volume":"7","author":"Y Alvarado","year":"2002","unstructured":"Alvarado Y, Bellm LA, Giles FJ (2002) Oral mucositis: time for more studies. Hematology 7:281\u2013289","journal-title":"Hematology"},{"key":"940_CR3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","volume":"82","author":"M Attal","year":"1993","unstructured":"Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, Laurent G, Pris J (1993) Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood 82:732\u2013736","journal-title":"Blood"},{"key":"940_CR4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood.V78.5.1205.1205","volume":"78","author":"JA Bianco","year":"1991","unstructured":"Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer JW (1991) Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78:1205\u20131211","journal-title":"Blood"},{"key":"940_CR5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","volume":"26","author":"N Blijlevens","year":"2008","unstructured":"Blijlevens N, Schwenkglenks M, Bacon P, D'Addio A, Einsele H, Maertens J, Niederwieser D, Rabitsch W, Roosaar A, Ruutu T, Schouten H, Stone R, Vokurka S, Quinn B, McCann S (2008) Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 26:1519\u20131525","journal-title":"J Clin Oncol"},{"key":"940_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2188\/jea.JE20080061","volume":"19","author":"Y Doi","year":"2009","unstructured":"Doi Y, Ninomiya T, Hata J, Yonemoto K, Tanizaki Y, Arima H, Liu Y, Rahman M, Iida M, Kiyohara Y (2009) Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan. J Epidemiol 19:56\u201362","journal-title":"J Epidemiol"},{"key":"940_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(03)00668-6","volume":"3","author":"JP Donnelly","year":"2003","unstructured":"Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP (2003) Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 3:405\u2013412","journal-title":"Lancet Infect Dis"},{"key":"940_CR8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s001080050721","volume":"42","author":"A Eigler","year":"2001","unstructured":"Eigler A, Loher F, Endres S (2001) 34. Internist (Berl) 42:28\u201334","journal-title":"Internist (Berl)"},{"key":"940_CR9","first-page":"325","volume":"15","author":"J Eilers","year":"1988","unstructured":"Eilers J, Berger AM, Petersen MC (1988) Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 15:325\u2013330","journal-title":"Oncol Nurs Forum"},{"key":"940_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1703817","volume":"31","author":"D Eisen","year":"2003","unstructured":"Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M (2003) Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Bone Marrow Transplant 31:51\u201355","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl","key":"940_CR11","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.clinthera.2007.12.004","volume":"29","author":"JM Fall-Dickson","year":"2007","unstructured":"Fall-Dickson JM, Ramsay ES, Castro K, Woltz P, Sportes C (2007) Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. Clin Ther 29(Suppl):2547\u20132561","journal-title":"Clin Ther"},{"issue":"Suppl B","key":"940_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/12.suppl_B.161","volume":"12","author":"E Gluckman","year":"1983","unstructured":"Gluckman E, Lotsberg J, Devergie A, Zhao XM, Melo R, Gomez-Morales M, Mazeron MC, Perol Y (1983) Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation. J Antimicrob Chemother 12(Suppl B):161\u2013167","journal-title":"J Antimicrob Chemother"},{"key":"940_CR13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bmj.287.6389.384","volume":"287","author":"IM Hann","year":"1983","unstructured":"Hann IM, Prentice HG, Blacklock HA, Ross MG, Brigden D, Rosling AE, Burke C, Crawford DH, Brumfitt W, Hoffbrand AV (1983) Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) 287:384\u2013388","journal-title":"Br Med J (Clin Res Ed)"},{"key":"940_CR14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.35.3.791-795.1997","volume":"35","author":"MV Jacobs","year":"1997","unstructured":"Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM (1997) A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35:791\u2013795","journal-title":"J Clin Microbiol"},{"key":"940_CR15","doi-asserted-by":"crossref","unstructured":"Kramer MA, Uitenbroek DG, Ujcic-Voortman JK, Pfrommer C, Spaargaren J, Coutinho RA, Dukers-Muijrers NH (2008) Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, the Netherlands Euro Surveill 13","DOI":"10.2807\/ese.13.24.18904-en"},{"key":"940_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(93)90082-A","volume":"116","author":"W Liedtke","year":"1993","unstructured":"Liedtke W, Opalka B, Zimmermann CW, Lignitz E (1993) Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 116:6\u201311","journal-title":"J Neurol Sci"},{"key":"940_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1053\/bbmt.2002.v8.abbmt080662","volume":"8","author":"JL Liesveld","year":"2002","unstructured":"Liesveld JL, Abboud CN, Ifthikharuddin JJ, Lancet JE, Wedow LA, Oliva J, Stamm CG, Nichols D (2002) Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients. Biol Blood Marrow Transplant 8:662\u2013665","journal-title":"Biol Blood Marrow Transplant"},{"key":"940_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","volume":"33","author":"RM Logan","year":"2007","unstructured":"Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33:448\u2013460","journal-title":"Cancer Treat Rev"},{"key":"940_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.olq.0000161188.82905.b7","volume":"32","author":"D Malvy","year":"2005","unstructured":"Malvy D, Halioua B, Lancon F, Rezvani A, Bertrais S, Chanzy B, Daniloski M, Ezzedine K, Malkin JE, Morand P, De Labareyre C, Hercberg S, El Hasnaoui A (2005) Epidemiology of genital herpes simplex virus infections in a community-based sample in France: results of the HERPIMAX study. Sex Transm Dis 32:499\u2013505","journal-title":"Sex Transm Dis"},{"key":"940_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcv.2004.03.002","volume":"30","author":"F Morfin","year":"2004","unstructured":"Morfin F, Bilger K, Boucher A, Thiebaut A, Najioullah F, Bleyzac N, Raus N, Bosshard S, Aymard M, Michallet M, Thouvenot D (2004) HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol 30:341\u2013345","journal-title":"J Clin Virol"},{"key":"940_CR21","first-page":"126","volume":"34","author":"PO Mulder","year":"1989","unstructured":"Mulder PO, Schroder P, de Vries-Hospers HG, van der Geest S, Sleijfer DT, Mulder NH, de Vries EG (1989) Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumours. Neth J Med 34:126\u2013131","journal-title":"Neth J Med"},{"key":"940_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jmv.1890360213","volume":"36","author":"A Pohl-Koppe","year":"1992","unstructured":"Pohl-Koppe A, Dahm C, Elgas M, Kuhn JE, Braun RW, ter Meulen V (1992) The diagnostic significance of the polymerase chain reaction and isoelectric focusing in herpes simplex virus encephalitis. J Med Virol 36:147\u2013154","journal-title":"J Med Virol"},{"key":"940_CR23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/0003-4819-99-6-773","volume":"99","author":"R Saral","year":"1983","unstructured":"Saral R, Ambinder RF, Burns WH, Angelopulos CM, Griffin DE, Burke PJ, Lietman PS (1983) Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med 99:773\u2013776","journal-title":"Ann Intern Med"},{"key":"940_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJM198107093050202","volume":"305","author":"R Saral","year":"1981","unstructured":"Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS (1981) Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 305:63\u201367","journal-title":"N Engl J Med"},{"key":"940_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.soncn.2003.10.003","volume":"20","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) Pathobiology of mucositis. Semin Oncol Nurs 20:11\u201315","journal-title":"Semin Oncol Nurs"},{"key":"940_CR26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995\u20132025","journal-title":"Cancer"},{"key":"940_CR27","first-page":"357","volume":"12","author":"M Stockschlader","year":"1993","unstructured":"Stockschlader M, Kalhs P, Peters S, Zeller W, Kruger W, Kabisch H, Lechner K, Zander A (1993) Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 12:357\u2013362","journal-title":"Bone Marrow Transplant"},{"key":"940_CR28","first-page":"203","volume":"13","author":"RH Jagt van der","year":"1994","unstructured":"van der Jagt RH, Pari G, McDiarmid SA, Boisvert DM, Huebsch LB (1994) Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 13:203\u2013207","journal-title":"Bone Marrow Transplant"},{"key":"940_CR29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-100-6-823","volume":"100","author":"JC Wade","year":"1984","unstructured":"Wade JC, Newton B, Flournoy N, Meyers JD (1984) Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 100:823\u2013828","journal-title":"Ann Intern Med"},{"key":"940_CR30","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1345\/aph.1A434","volume":"36","author":"DI Warkentin","year":"2002","unstructured":"Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox VC, Ransier A, Barnett MJ, Marra F (2002) Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients. Ann Pharmacother 36:1525\u20131531","journal-title":"Ann Pharmacother"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-010-0940-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0940-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T05:28:23Z","timestamp":1635658103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-010-0940-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,11]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1007\/s00520-010-0940-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,11]]}}}